TP53 and diabetic cardiomyopathy: Results showed that genes with the low‐DERs in promoters were significantly enriched in pathways like RNA degradation, ubiquitin mediated proteolysis, and diabetic cardiomyopathy, p53 signaling pathway (Figure 4e).